Chinese Journal of Cancer
The Chinese Journal of Cancer is indexed in Science Citation Index (SCI) Expanded Yi-Xin Zeng1, Wei Zhang2, Chao-Nan Qian3, Rui-Hua Xu3 and Ji Ruan4
On July 22, 2014, the Chinese Journal of Cancer (CJC ) received a notification from Thomson Reuters that the publications of our journal starting from 2012 have been accepted for coverage in Science Citation Index Expanded, available at the Web of Science, Core Collection, Biological Abstracts, and Biosis Previews. What this means in practical terms is that CJC will receive its first official impact factor (IF) in 2015. This is an important milestone in the history of CJC . As an official journal of the Chinese Anti-Cancer Association (CACA), CJC has been a leading cancer journal in China and has published monthly since 2000. To meet the requirement of globalization in cancer research and treatment, CJC has undergone a transformation from a Chinese language journal to an English language journal in 2010 and has also become the official journal of the US Chinese Anti-Cancer Association (USCACA). With an international editorial board and English language editors, CJC publishes peer-reviewed, open access, and English language scientific articles in the areas of basic, clinical, and translational cancer research that aim to improve human health through understanding cancer, preventing cancer onset, reducing cancer mortality, and improving the quality of life of cancer survivors in the world. CJC especially promotes international collaborations and serves as a unique forum for discoveries in cancer types such as Authors′ Affiliations: 1Peking Union Medical College, Beijing 100730, P. R. China; 2Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; 3State Key Laboratory of Oncology in South China and Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong 510060, P. R. China; 4Department of Editorial Office, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong 510060, P. R. China. Yi-Xin Zeng is the Editor-in-Chief of the Chinese Journal of Cancer; Wei Zhang, Chao-Nan Qian, and Rui-Hua Xu are senior Associate Editors of the Chinese Journal of Cancer; Ji Ruan is the Director of Editorial Office. doi: 10.5732/cjc.014.10115
nasopharyngeal carcinoma (NPC), liver cancer, gastric cancer, esophageal cancer, which are common cancer types in China and Asia. In addition, CJC emphasizes timely cancer issues such as air pollution and cancer, as well as immunotherapy of cancer. The historical impact of CJC is indicated by its indexation in the MedLine (2002), PubMed Center, Directory of Open Access Journals (DOAJ), Scopus, the Western Pacific Region Index Medicus, and CA databases. The impact of CJC in the international arena has been steadily increasing after it has become an English language journal in 2010. We have enjoyed strong international support and joined by many internationally renowned cancer investigators. Most importantly, we have received and published many high level manuscripts from established authors from many countries/regions. We are very pleased to see that the historical impact of CJC has been markedly augmented in the world. During the last three years, CJC papers have been cited by many reputable journals including Cell , Cancer Cell , Stem Cells , Nature Reviews Cancer , Journal of Clinical Investigation , Oncogene , Cancer Research , and Journal of Biological Chemistry . The estimated impact factor of CJC has been growing steadily. CJC is supported by the International Impactpromoting Program for Chinese Sci-Tech Journals for 3 consecutive years. CJC was entitled Top 100 Outstanding Academic Journals in China for four times from 2010 to 2013 and was recognized as one of the most internationally influential science journals in China in 2013. We are very excited that CJC is now officially recognized by the Thomson Reuters and publications in CJC since 2012 will be tracked for citation toward its calculation of impact factor. On this high level, CJC will continue to embrace critical thoughts, insightful studies, novel technologies, and meaningful clinical experiences. We would like to thank the evaluators at the Thomson Reuters for recognizing the value of CJC . We want to thank all the editorial board members for their guidance and all the editorial staff for their tireless work. We especially want to thank all our authors for contributing
Chinese Anti-Cancer Association 367
Yi-Xin Zeng et al.
The Chinese Journal of Cancer is indexed in Science Citation Index (SCI) Expanded
their wonderful work and all the reviewers for providing the top notch professional expertise. This milestone, as important as it is, is a new beginning. Much work is needed to conquer cancer. We need to
communicate and collaborate. We need to dream and act. Let CJC be the best forum and media for our efforts to fight cancer globally.
The publications of CJC since 2012 have been accepted for coverage in Science Citation Index (SCI) Expanded
368 Chin J Cancer; 2014; Vol. 33 Issue 8
Chinese Journal of Cancer